← Leaderboards
Olivia Ifeoma Okereke
Brigham And Women'S Hospital
$11,031,577
Attributed
$11,031,577
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,521,512 · 7
By mechanism
R01$8,504,154 · 2
P30$5,188,855 · 3
R56$1,297,413 · 1
K08$531,090 · 1
Top collaborators
- Ana-Maria Vranceanu2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Frank M Sacks$39,642,820
- Rulla M Tamimi$15,389,173
- Julie Lin$2,235,010
- Paul R Conlin$6,611,270
- Dariush Mozaffarian$28,150,783
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesParticipantElderlyCohortWomanFollow-UpRisk FactorsFundingHigh RiskPersonsInnovationPreventionEnsureMental DepressionSamplingAnxietyBiological MarkersAgedBloodMental HealthDepressive SymptomsAlzheimer&AposMoodsAging
Grant awards (31)
MassaChusetts General Hospital ROybal CeNter For BehavIoral Dyadic ResEarch in Alzheimer's Disease and Related Dementias (CONFIDE-ADRD)$1,165,684
P30 · FY2025 · AG
Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg (Mass-ENVISION)$689,736
P30 · FY2025 · AG · contact PI
Leadership and Administrative Core (LAC)$227,307
P30 · FY2025 · AG · contact PI
MassaChusetts General Hospital ROybal CeNter For BehavIoral Dyadic ResEarch in Alzheimer's Disease and Related Dementias (CONFIDE-ADRD)$1,203,241
P30 · FY2024 · AG
Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg (Mass-ENVISION)$695,521
P30 · FY2024 · AG · contact PI
Leadership and Administrative Core (LAC)$229,998
P30 · FY2024 · AG · contact PI
Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg (Mass-ENVISION)$735,753
P30 · FY2023 · AG · contact PI
Leadership and Administrative Core (LAC)$241,615
P30 · FY2023 · AG · contact PI
VITAL-DEP (VITamin D and OmegA 3 TriaL-Depression Endpoint Prevention)$1,297,413
R56 · FY2022 · MH · contact PI
VITAL-DEP Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$626,170
R01 · FY2019 · MH · contact PI
VITAL-DEP Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$758,714
R01 · FY2018 · MH · contact PI
Neuropsychiatric symptoms, cognitive aging and DNA methylation age in the VITAL-DEP cohort$341,815
R01 · FY2018 · MH · contact PI
VITAL-DEP Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$698,970
R01 · FY2017 · MH · contact PI
Racial and Ethnic Disparities in Depression Care Utilization and Adherence among Older Adults$153,238
R01 · FY2017 · MH · contact PI
VITAL-DEP Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$703,609
R01 · FY2016 · MH · contact PI
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life$402,265
R01 · FY2016 · MH · contact PI
VITAL-DEP Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$852,936
R01 · FY2015 · MH · contact PI
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life$601,097
R01 · FY2015 · MH · contact PI
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life$110,625
R01 · FY2015 · MH · contact PI
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$461,562
R01 · FY2014 · MH · contact PI
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life$441,875
R01 · FY2014 · MH · contact PI
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life$53,025
R01 · FY2014 · MH · contact PI
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$444,101
R01 · FY2013 · MH · contact PI
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life$440,625
R01 · FY2013 · MH · contact PI
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$468,560
R01 · FY2012 · MH · contact PI
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$454,704
R01 · FY2011 · MH · contact PI
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline$133,380
K08 · FY2011 · AG · contact PI
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL$490,263
R01 · FY2010 · MH · contact PI
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline$133,380
K08 · FY2010 · AG · contact PI
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline$132,570
K08 · FY2009 · AG · contact PI
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline$131,760
K08 · FY2008 · AG · contact PI